These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 516837)

  • 1. [Improvement of drug therapy for essential hypertension].
    Julich H; Behn P
    Z Gesamte Inn Med; 1979 Sep; 34(18):519-22. PubMed ID: 516837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug-taking behavior of workers with hypertension in the health service of the Wismut public health district].
    Zwingenberger W; Nestler K; Faulhaber HD; Beier C; Selig R
    Z Gesamte Inn Med; 1988 May; 43(10):262-5. PubMed ID: 3414141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical treatment of hypertension--what treatment for what patients?].
    Zidek W; Tepel M; van der Giet M
    MMW Fortschr Med; 2004 May; 146(22):31-4. PubMed ID: 15373106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diuretics in the treatment of hypertension].
    Dzúrik R; Fedelesová V; Dzúriková V; Spustová V
    Vnitr Lek; 1993 Sep; 39(9):909-15. PubMed ID: 8212647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations in the long-term treatment of hypertension.
    Graham RM
    Clin Ther; 1983; 5(3):224-33. PubMed ID: 6342783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High blood pressure is still being inadequately treated].
    Patyna WD; Matzdorff F
    Med Klin; 1981 Apr; 76(9):261-4. PubMed ID: 6116171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
    Stewart JR; Yeun JY
    Minerva Med; 2003 Aug; 94(4):215-27. PubMed ID: 14605587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renaissance of diuretics in the treatment of hypertension].
    Hörl WH
    Wien Klin Wochenschr; 1999 Nov; 111(21):903-7. PubMed ID: 10599155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive cardiovascular assessment of indapamide in patients with essential hypertension.
    Dunn FG; Hillis WS; Tweddel A; Rae AP; Lorimer AR
    Postgrad Med J; 1981; 57 Suppl 2():19-22. PubMed ID: 7322955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension in practice--problem and therapy experiences].
    Matter H
    Wien Med Wochenschr; 1982; 132 Spec No():14-6. PubMed ID: 6123197
    [No Abstract]   [Full Text] [Related]  

  • 15. Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE Study.
    Aranda P; Tamargo J; Aranda FJ; Luque M; López-Garcia-Franco A
    Blood Press Suppl; 1997; 1():11-6. PubMed ID: 9285102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of patients with hypertension resistant to treatment].
    Girerd X; Hanon O
    Rev Prat; 1999 Mar; 49(5):527-31. PubMed ID: 10358403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with Pharmachim's Chlophazolin of hypertension and symptomatic hypertonia].
    Koĭchev A; Belovezhdov N; Chakŭrski I; Stefanov G; Angelova I
    Vutr Boles; 1986; 25(1):72-7. PubMed ID: 2872753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. South Australian hypertension survey. General practitioner experiences with drug treatment.
    Steven ID; Wilson DH; Wakefield MA; Beilby J; Coffey GA; Esterman AJ; Golding AP; Graham NM; Litt JC; Rohrsheim RA
    Med J Aust; 1992 May; 156(9):641-4. PubMed ID: 1625618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of metolazone in the long-term treatment of essential hypertension.
    Cangiano JL; Campos JA; Trevino A; Ramirez-Gonzalez R; Ramirez-Muzo O
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):778-85. PubMed ID: 4217244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development and drug correction of therapy resistance in chronic antihypertensive use].
    Dück KD
    Z Gesamte Inn Med; 1980 Oct; 35(20):supply 123-5. PubMed ID: 6782774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.